LONDON (AP) – Shares in Anglo-Swedish drugmaker AstraZeneca plunged as much as 17 percent Thursday after a new lung cancer treatment proved less successful than the company had hoped. AstraZeneca […]
© 2024 Delaware Business Times
Important notice for access to your Delaware Business Times “Insider” content
Flash Sale! Subscribe to Delaware Business Times and save 50%.
Limited time offer. New subscribers only.
SUMMER FLASH SALE!
Subscribe to Delaware Business Times and save 50%